Evidence map›Paper›PMID 37635261›Full record

ArticleGenome biology2023

Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer.

Kim Wong, Federico Abascal, Latasha Ludwig, Heike Aupperle-Lellbach, Julia Grassinger, Colin W Wright, Simon J Allison, Emma Pinder, Roger M Phillips, Laura P Romero and 44 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. The oncogenome of the domestic cat.Science (New York, N.Y.) · 2026
    Article
  4. Article
  5. Review
  6. Toxic Threats from the FernInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Review
  9. Bracken Fern Carcinogen, Ptaquiloside, Forms a GuanineJournal of agricultural and food chemistry · 2025
    Article
  10. Article
  11. Review
  12. [Comparative pathology in oncology-Best practice].Pathologie (Heidelberg, Germany) · 2024
    Review
  13. Review of Molecular Technologies for Investigating Canine Cancer.Animals : an open access journal from MDPI · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors at 20 institutions in 17 countries.

Kim WongExperimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.ORCID http://orcid.org/0000-0002-0984-1477
Federico AbascalExperimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Latasha LudwigDepartment of Pathobiology, University of Guelph, Guelph, ON, Canada.
Heike Aupperle-LellbachLaboklin GmbH & Co. KG, Bad Kissingen, Germany and Institute of Pathology, Department Comparative Experimental Pathology, School of Medicine, Technical University of Munich, Munich, Germany.
Julia GrassingerLaboklin GmbH & Co. KG, Bad Kissingen, Germany and Institute of Pathology, Department Comparative Experimental Pathology, School of Medicine, Technical University of Munich, Munich, Germany.
Colin W WrightSchool of Pharmacy and Medical Sciences, University of Bradford, West Yorkshire, UK.
Simon J AllisonDepartment of Pharmacy, University of Huddersfield, Queensgate, Huddersfield, UK.
Emma PinderDepartment of Pharmacy, University of Huddersfield, Queensgate, Huddersfield, UK.
Roger M PhillipsDepartment of Pharmacy, University of Huddersfield, Queensgate, Huddersfield, UK.
Laura P RomeroDepartmento de Patología, Facultad de Medicina Veterinaria Y Zootecnia, Universidad Nacional Autónoma de México (UNAM), CDMX, Mexico City, México.
Arnon GalDepartment of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Patrick J RoadyDepartment of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Isabel PiresDepartment of Veterinary Science, CECAV-Veterinary and Animal Research Center, University of Trás-Os-Montes and Alto Douro, Vila Real, Portugal.
Franco GuscettiInstitute of Veterinary Pathology, University of Zurich, Zurich, Switzerland.
John S MundaySchool of Veterinary Science, Massey University, Palmerston North, New Zealand.
Maria C PeleteiroFaculty of Veterinary Medicine, Centre for Interdisciplinary Research in Animal Health (CIISA), University of Lisbon, Lisbon, Portugal.
Carlos A PintoFaculty of Veterinary Medicine, Centre for Interdisciplinary Research in Animal Health (CIISA), University of Lisbon, Lisbon, Portugal.
Tânia CarvalhoChampalimaud Foundation, Lisbon, Portugal.
João CotaFaculty of Veterinary Medicine, Centre for Interdisciplinary Research in Animal Health (CIISA), University of Lisbon, Lisbon, Portugal.
Elizabeth C Du PlessisDivision of Pathology, IDEXX Laboratories, Kyalami, South Africa.
Fernando Constantino-CasasDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.
Stephanie PlogThe Veterinary Pathology Group (VPG), Bristol, UK.
Lars MoeDepartment of Companion Animal Clinical Sciences, Norwegian University of Life Sciences, Ås, Norway.
Simone de BrotInstitute of Animal Pathology, COMPATH, University of Bern, Bern, Switzerland.
Ingrid BemelmansCerba Vet, Île-de-France, 91300, Massy, France.
Renée Laufer AmorimVeterinary Clinic Department, School of Veterinary Medicine and Animal Science, São Paulo State University, Botucatu, Brazil.
Smitha R GeorgyDepartment of Anatomic Pathology, Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Victoria, Australia.
Justina PradaDepartment of Veterinary Science, CECAV-Veterinary and Animal Research Center, University of Trás-Os-Montes and Alto Douro, Vila Real, Portugal.
Jorge Del PozoRoyal Dick School of Veterinary Sciences, University of Edinburgh, Roslin, Scotland, UK.
Marianne Heimann, Anapet, Montigny-Le-Tilleul, Belgium.
Louisiane de Carvalho NunesDepartamento de Medicina Veterinária, Universidade Federal Do Espírito Santo, Alegre, ES, Brazil.
Outi SimolaFinnish Food Authority, Helsinki, Finland.
Paolo PazziDepartment of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa.
Johan SteylDepartment of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa.
Rodrigo UbukataE+ Especialidades Veterinárias - Veterinary Oncology, São Paulo, Brazil.
Peter VajdovichDepartment of Clinical Pathology and Oncology, University of Veterinary Medicine Budapest, Budapest, Hungary.
Simon L PriestnallDepartment of Pathobiology and Population Sciences, The Royal Veterinary College, Hatfield, UK.
Alejandro Suárez-BonnetDepartment of Pathobiology and Population Sciences, The Royal Veterinary College, Hatfield, UK.
Franco RopertoDipartimento Di Biologia, Università Degli Studi Di Napoli Federico II, Napoli, Italy.
Francesca MillantaDepartment of Veterinary Sciences, University of Pisa, Pisa, Italy.
Chiara PalmieriSchool of Veterinary Science, The University of Queensland, Brisbane, QLD, Australia.
Ana L OrtizSchool of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Claudio S L BarrosFaculdade de Medicina Veterinária E Zootecnia, Universidade Federal de Mato Grosso Do Sul, Campo Grande, MS, Brazil.
Aldo GavaPathology Laboratory of the Centro de Ciencias Agro-Veterinarias, Universidade Do Estado de Santa Catarina, Lages, SC, Brazil.
Minna E SöderströmDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Marie O'DonnellDepartment of Pathology, Western General Hospital, Edinburgh, Scotland, UK.
Robert KlopfleischInstitute of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
Andrea Manrique-RincónExperimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Inigo MartincorenaExperimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Ingrid FerreiraExperimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Mark J ArendsUniversity of Edinburgh Division of Pathology, Cancer Research UK Edinburgh Cancer Centre, Institute of Genetics & Cancer, Edinburgh, Scotland, UK.
Geoffrey A WoodDepartment of Pathobiology, University of Guelph, Guelph, ON, Canada.
David J AdamsExperimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. da1@sanger.ac.uk.ORCID http://orcid.org/0000-0001-9490-0306
Louise van der WeydenExperimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.ORCID http://orcid.org/0000-0002-0645-1879
Wellcome Sanger Institute · GBUniversity of Huddersfield · GBUniversity of Lisbon · PTLaboklin (Germany) · DERoyal Veterinary College · GBUniversity of Guelph · CAUniversity of Illinois Urbana-Champaign · USUniversity of Pretoria · ZAUniversity of Trás-os-Montes and Alto Douro · PTAssociação Brasileira de Oncologia Veterinária · BRAt Bristol · GBChampalimaud Foundation · PTEdinburgh Cancer Research · GBFinnish Food Authority · FIFreie Universität Berlin · DEIDEXX Laboratories (France) · FRMassey University · NZNorwegian University of Life Sciences · NOThe University of Melbourne · AUThe University of Queensland · AU

Funding

Cancer Research UK 21777Cancer Research UK C20510/A13031Medical Research Council MR/V000292/1Wellcome Trust WT098051
6 · The paper itself

Abstract

backgroundIn humans, muscle-invasive bladder cancer (MIBC) is highly aggressive and associated with a poor prognosis. With a high mutation load and large number of altered genes, strategies to delineate key driver events are necessary. Dogs and cats develop urothelial carcinoma (UC) with histological and clinical similarities to human MIBC. Cattle that graze on bracken fern also develop UC, associated with exposure to the carcinogen ptaquiloside. These species may represent relevant animal models of spontaneous and carcinogen-induced UC that can provide insight into human MIBC.

resultsWhole-exome sequencing of domestic canine (n = 87) and feline (n = 23) UC, and comparative analysis with human MIBC reveals a lower mutation rate in animal cases and the absence of APOBEC mutational signatures. A convergence of driver genes (ARID1A, KDM6A, TP53, FAT1, and NRAS) is discovered, along with common focally amplified and deleted genes involved in regulation of the cell cycle and chromatin remodelling. We identify mismatch repair deficiency in a subset of canine and feline UCs with biallelic inactivation of MSH2. Bovine UC (n = 8) is distinctly different; we identify novel mutational signatures which are recapitulated in vitro in human urinary bladder UC cells treated with bracken fern extracts or purified ptaquiloside.

conclusionCanine and feline urinary bladder UC represent relevant models of MIBC in humans, and cross-species analysis can identify evolutionarily conserved driver genes. We characterize mutational signatures in bovine UC associated with bracken fern and ptaquiloside exposure, a human-linked cancer exposure. Our work demonstrates the relevance of cross-species comparative analysis in understanding both human and animal UC.

Indexed as

Carcinoma, Transitional CellCat DiseasesDog DiseasesUrinary Bladder NeoplasmsAnimalsCarcinogensCatsCattleDogsHumansIndansMusclesSesquiterpenesCarcinogensIndansptaquilosideSesquiterpenesBovineBrackenCancerCanineCross-species comparisonFelineMutational signaturePtaquilosidePteridium aquilinumUrinary bladder

Identifiers

PMID37635261
PMCPMC10464500
OpenAlexW4386200358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.